Ebola Outbreak in DRC and Uganda: CDC Issues Warning as Cases Spread

The Centers for Disease Control and Prevention (CDC) has issued a Health Advisory Notice following a rapidly evolving Ebola outbreak in DRC and Uganda that has now spread across borders.

The outbreak, first confirmed by the DRC Ministry of Health on May 15, 2026, has been characterized by the World Health Organization as concerning for its “speed and scale,” with cases now reported in multiple locations across the affected region.

Current Situation

• Initial cases identified in Ituri Province, DRC, a region marked by active conflict and high population movement due to mining activities
• Confirmed cases have now been reported in Uganda’s capital, Kampala, raising concerns about urban spread
• An American surgeon who contracted Ebola while treating patients in Ituri Province was evacuated to Germany for treatment
• The White House has indicated that additional Americans who contract Ebola may be evacuated to European facilities rather than returned to the United States

Enhanced Screening Measures

On May 18, the CDC and the Department of Homeland Security announced enhanced travel screening, entry restrictions, and public health measures aimed at preventing Ebola from entering the United States. These measures include:

• Enhanced screening at major international airports for travelers from affected regions
• Travel restrictions for non-U.S. citizens who have been in affected areas
• Distribution of health alert notices to travelers
• Coordination with international health authorities for contact tracing

Why This Outbreak Is Different

The current outbreak presents several challenges that distinguish it from previous Ebola outbreaks in the region:

• Conflict zone: The epicenter in Ituri Province is in an area of active armed conflict, making surveillance and response efforts extremely difficult
• Population movement: The area is a major mining zone with high levels of population movement, increasing the risk of spread
• Urban spread: Cases in Kampala represent the first urban transmission in this outbreak, raising the stakes significantly
• International travel: The affected region has transportation links to multiple international destinations

Ebola: Key Facts

Ebola virus disease (EVD) is a severe, often fatal illness with a case fatality rate ranging from 25% to 90% depending on the outbreak and access to healthcare. The virus is transmitted to people from wild animals and spreads through human-to-human transmission via direct contact with bodily fluids.

Symptoms include sudden onset of fever, fatigue, muscle pain, headache, and sore throat, followed by vomiting, diarrhea, rash, and in severe cases, internal and external bleeding. Early supportive care improves survival rates.

International Response

The WHO has deployed emergency response teams to both DRC and Uganda, and experimental vaccines and therapeutics are being mobilized. The rVSV-ZEBOV vaccine, which has been effective in previous outbreaks, is being used in a ring vaccination strategy around confirmed cases.

“The speed and scale of this outbreak is concerning,” said WHO Director-General Tedros Adhanom Ghebreyesus. “We are working around the clock with national authorities and partners to contain the spread.”

Frequently Asked Questions

What are the symptoms of Ebola?

Symptoms include sudden onset of fever, fatigue, muscle pain, headache, and sore throat, followed by vomiting, diarrhea, rash, and in severe cases, internal and external bleeding. Symptoms typically appear 2 to 21 days after exposure.

Is Ebola spreading to the United States?

As of the latest reports, all confirmed cases remain in Central Africa. The CDC has implemented enhanced screening at major U.S. airports for travelers from affected regions and has imposed travel restrictions for non-U.S. citizens who have been in affected areas.

Is there a vaccine for Ebola?

Yes, the rVSV-ZEBOV vaccine has been effective in previous outbreaks and is being used in a ring vaccination strategy around confirmed cases in the current outbreak. WHO has also mobilized experimental therapeutics to the affected regions.

Image credit: Miguel Á. Padriñán / Pexels